{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:53:13Z","timestamp":1790949193943,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["NSMC(A)2024(033"],"award-info":[{"award-number":["NSMC(A)2024(033"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["25NSFSC2024"],"award-info":[{"award-number":["25NSFSC2024"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejps.2025.107051","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T19:12:44Z","timestamp":1740597164000},"page":"107051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring the novel role and mechanistic insights of skeletal muscle relaxant cyclobenzaprine hydrochloride in esophageal squamous cell carcinoma treatment"],"prefix":"10.1016","volume":"210","author":[{"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoju","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejps.2025.107051_bib0001","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.4103\/njcp.njcp_104_21","article-title":"Mismatch repair protein expressions in cohort of colorectal carcinoma patients in Lagos","volume":"24","author":"Badmos","year":"2021","journal-title":"Niger. J. Clin. Pract."},{"issue":"10","key":"10.1016\/j.ejps.2025.107051_bib0002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0028-3908(76)90021-6","article-title":"Effects of cyclobenzaprine on brainstem motor systems","volume":"15","author":"Barnes","year":"1976","journal-title":"Neuropharmacology."},{"issue":"3","key":"10.1016\/j.ejps.2025.107051_bib0003","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0004","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2383886","article-title":"Design, synthesis, and evaluation of novel stilbene derivatives that degrade acidic nucleoplasmic DNA-binding protein 1 (And1) and synergize with PARP1 inhibitor in NSCLC cells","volume":"39","author":"Chen","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0005","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820978817","article-title":"Identification of key modules and hub genes involved in esophageal squamous cell carcinoma tumorigenesis using WCGNA","volume":"27","author":"Chen","year":"2020","journal-title":"Cancer Control"},{"issue":"5","key":"10.1016\/j.ejps.2025.107051_bib0006","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1093\/nar\/gkw1212","article-title":"And-1 coordinates with CtIP for efficient homologous recombination and DNA damage checkpoint maintenance","volume":"45","author":"Chen","year":"2017","journal-title":"Nucleic. Acids. Res."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0007","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12957-023-03187-3","article-title":"Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy","volume":"21","author":"Cui","year":"2023","journal-title":"World J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.ejps.2025.107051_bib0008","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","article-title":"Targeting SOCS proteins to control JAK-STAT signalling in disease","volume":"40","author":"Durham","year":"2019","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2025.107051_bib0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fonc.2020.00461","article-title":"WDHD1 Leads to cisplatin resistance by promoting MAPRE2 ubiquitination in lung adenocarcinoma","volume":"10","author":"Gong","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2025.107051_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2017.05.033","article-title":"Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition","volume":"451","author":"Groner","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"issue":"4","key":"10.1016\/j.ejps.2025.107051_bib0011","first-page":"309","article-title":"National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)","volume":"34","year":"2022","journal-title":"Chin. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.ejps.2025.107051_bib0012","first-page":"226","article-title":"Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics","volume":"14","author":"Huang","year":"2013","journal-title":"Curr. Drug Metab."},{"issue":"2","key":"10.1016\/j.ejps.2025.107051_bib0013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-9525(00)89000-9","article-title":"Jaks and stats in signaling by the cytokine receptor superfamily","volume":"11","author":"Ihle","year":"1995","journal-title":"Trends. Genet."},{"issue":"5","key":"10.1016\/j.ejps.2025.107051_bib0014","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0968-0004(94)90026-4","article-title":"Signaling by the cytokine receptor superfamily: JAKs and STATs","volume":"19","author":"Ihle","year":"1994","journal-title":"Trends. Biochem. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2025.107051_bib0015","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1074\/jbc.M112.429266","article-title":"Acidic nucleoplasmic DNA-binding protein (And-1) controls chromosome congression by regulating the assembly of centromere protein A (CENP-A) at centromeres","volume":"288","author":"Jaramillo-Lambert","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cells9010217","article-title":"Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-2999(96)00402-5","article-title":"Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems","volume":"311","author":"Kobayashi","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejps.2025.107051_bib0018","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1002\/ctm2.627","article-title":"Discovery and characterization of potent and-1 inhibitors for cancer treatment","volume":"11","author":"Li","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.ejps.2025.107051_bib0019","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/nar\/gkw1241","article-title":"And-1 is required for homologous recombination repair by regulating DNA end resection","volume":"45","author":"Li","year":"2017","journal-title":"Nucleic. Acids. Res."},{"issue":"3","key":"10.1016\/j.ejps.2025.107051_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0021","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"Liau","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0022","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1038\/s41467-021-26983-5","article-title":"Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands","volume":"12","author":"Linossi","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejps.2025.107051_bib0023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.dld.2018.08.021","article-title":"MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma","volume":"51","author":"Liu","year":"2019","journal-title":"Dig. Liver. Dis."},{"issue":"51","key":"10.1016\/j.ejps.2025.107051_bib0024","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"20","key":"10.1016\/j.ejps.2025.107051_bib0025","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1158\/1078-0432.CCR-15-2822","article-title":"DS-8201a, A novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising antitumor efficacy with differentiation from T-DM1","volume":"22","author":"Ogitani","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"Suppl","key":"10.1016\/j.ejps.2025.107051_bib0026","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0092-8674(02)00701-8","article-title":"Cytokine signaling in 2002: new surprises in the Jak\/Stat pathway","volume":"109","author":"O'Shea","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2025.107051_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112421","article-title":"TLR4 inhibitors through inhibiting (MYD88-TRIF) pathway, protect against experimentally-induced intestinal (I\/R) injury","volume":"136","author":"Osman","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2025.107051_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115764","article-title":"A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder","volume":"334","author":"Parmenter","year":"2024","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.ejps.2025.107051_bib0029","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cytogfr.2006.09.008","article-title":"Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions","volume":"17","author":"Rico-Bautista","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.ejps.2025.107051_bib0030","first-page":"365","article-title":"Choosing a skeletal muscle relaxant","volume":"78","author":"See","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ejps.2025.107051_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108118","article-title":"The role of the STAT3 signaling transduction pathways in radioresistance","volume":"234","author":"Shih","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2025.107051_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113974","article-title":"Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response","volume":"301","author":"Sullivan","year":"2021","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0033","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.20076","article-title":"Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis","volume":"51","author":"Tofferi","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejps.2025.107051_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","article-title":"The potential and controversy of targeting STAT family members in cancer","volume":"60","author":"Verhoeven","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"23","key":"10.1016\/j.ejps.2025.107051_bib0035","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41388-024-03041-0","article-title":"ZBTB16 inhibits DNA replication and induces cell cycle arrest by targeting WDHD1 transcription in lung adenocarcinoma","volume":"43","author":"Wang","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0036","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","article-title":"Regulation of the innate and adaptive immune responses by stat-3 signaling in tumor cells","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.ejps.2025.107051_bib0037","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","article-title":"Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial","volume":"15","author":"Wilke","year":"2014","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0038","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/2211-5463.13519","article-title":"WDHD1 is over-expressed in nasopharyngeal carcinoma and may control the expression of ITGAV","volume":"13","author":"Wu","year":"2023","journal-title":"FEBS. Open. Bio"},{"key":"10.1016\/j.ejps.2025.107051_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5871188","article-title":"The involvement of WDHD1 in the occurrence of esophageal cancer as a downstream target of PI3K\/AKT pathway","volume":"2022","author":"Xian","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.ejps.2025.107051_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0041","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0042","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41392-020-00323-3","article-title":"Advances in targeted therapy for esophageal cancer","volume":"5","author":"Yang","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.ejps.2025.107051_bib0043","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.immuni.2012.01.010","article-title":"JAK's SOCS: a mechanism of inhibition","volume":"36","author":"Yoshimura","year":"2012","journal-title":"Immunity."},{"issue":"31","key":"10.1016\/j.ejps.2025.107051_bib0044","doi-asserted-by":"crossref","first-page":"20718","DOI":"10.1074\/jbc.M806711200","article-title":"Roles of human AND-1 in chromosome transactions in S phase","volume":"284","author":"Yoshizawa-Sugata","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ejps.2025.107051_bib0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.ejps.2025.107051_bib0046","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-023-01906-4","article-title":"Pharmacologic management of cancer-related pain in pregnant patients","volume":"83","author":"Zerfas","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2025.107051_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107969","article-title":"Signal transducer and activator of transcription 3 signaling in tumor immune evasion","volume":"230","author":"Zhang","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"15","key":"10.1016\/j.ejps.2025.107051_bib0048","doi-asserted-by":"crossref","first-page":"12494","DOI":"10.3390\/ijms241512494","article-title":"WD repeat and HMG box DNA binding protein 1: an oncoprotein at the hub of tumorigenesis and a novel therapeutic target","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2025.107051_bib0049","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13578-020-00524-x","article-title":"STAT3 plays an important role in DNA replication by turning on WDHD1","volume":"11","author":"Zhou","year":"2021","journal-title":"Cell Biosci."},{"issue":"13","key":"10.1016\/j.ejps.2025.107051_bib0050","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1128\/JVI.00513-16","article-title":"Role of WDHD1 in Human papillomavirus-mediated oncogenesis identified by transcriptional profiling of E7-expressing cells","volume":"90","author":"Zhou","year":"2016","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/j.ejps.2025.107051_bib0051","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1101\/gad.1585607","article-title":"Mcm10 and and-1\/CTF4 recruit DNA polymerase alpha to chromatin for initiation of DNA replication","volume":"21","author":"Zhu","year":"2007","journal-title":"Genes Dev."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:57:26Z","timestamp":1778558246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"alternative-id":["S0928098725000508"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107051","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the novel role and mechanistic insights of skeletal muscle relaxant cyclobenzaprine hydrochloride in esophageal squamous cell carcinoma treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107051"}}